United States · 
What does New Rhein invest in?
New Rhein invests most often at Series A (100% of the rounds on record), in sectors such as Longevity, Health-tech and E-health.
New Rhein highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A: 100% of its rounds
- 03
Sole investor in 1 rounds, median $12M
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- $100K – $50M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- LongevityHealth-techE-health
- Based in
- Philadelphia, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2026
1 round
- Feb
- 2018
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
IPIvan Philip GergelManaging Partner & Chief Medical OfficeriForm ADV
NGNayan Greg ParekhFounder & Managing PartneriForm ADV
RWRobert William CzesakChief Financial OfficeriForm ADV
SSSubhanu SaxenaManaging Partner & Chief Compliance OfficeriForm ADV
We also hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$291Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- NEW Rhein Healthcare Investors LLC
- SEC number
- CRD 300842
Funds on its Form ADV
5 private funds, $145M in gross assets · filed May 2024
- New Rhein Healthcare 18 L.P.Venture21 investors$41M
- New Rhein Healthcare 2021 (Lux) SCSPVenture19 investors$34M
- New Rhein Healthcare 18 (Parallel) SCSPVenture8 investors$30M
- New Rhein Healthcare 2021 PrivakVenture7 investors$20M
- New Rhein Healthcare 2021 (DE) L.P.Venture26 investors$19M
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Investor Portal
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.